Testim Testosterone Lawsuits Advance in U.S. District Court as Federal Regulators Meet to Investigate Testosterone Heart Attack Risk - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
August 29, 2014 Newswires
Share
Share
Post
Email

Testim Testosterone Lawsuits Advance in U.S. District Court as Federal Regulators Meet to Investigate Testosterone Heart Attack Risk

PR Web

St. Louis, MO (PRWEB) August 29, 2014

Testim testosterone lawsuits forged ahead last week in U.S. District Court, report attorneys at The Onder Law Firm who are handling Testim and other testosterone therapy claims. Meanwhile, federal regulators are soon to convene in Maryland to investigate the cardiovascular risks of testosterone therapy treatments. Further information and Testim lawsuit news updates are available at TestimTestosteroneLawsuitCenter.com.

According to a study* cited in a January 31, 2013 FDA Safety Communication**, Testim and other testosterone drugs cause a 30% increase in the risk of stroke, heart attack and death. The study, "Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels," was published in the Journal of the American Medical Association (JAMA) in November 2013. This research, along with another study, prompted the FDA to warn the public of the potential for heart attack, stroke, and death resulting from testosterone therapies such as Testim.

Members of the FDA'sBone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee are scheduled*** to meet on September 17, 2014, for an in-depth investigation of the cardiovascular dangers of testosterone drugs such as Testim. While the medical community awaits the experts' further analysis, testosterone lawsuits advance in U.S. District Courts.

Persons who have suffered heart attack, stroke, or death while taking Testim or another testosterone product have filed lawsuits against manufacturers of testosterone products on the basis of the FDA warning. Initially, testosterone lawsuits were grouped together by product, where persons who had taken Testim were filing separate claims from persons who had taken other testosterone products. However, testosterone lawsuits in general have been grouped together as a Multi-District Litigation (MDL) in U.S. District Court in Northern Illinois. According to court documents as of August 25, 2014, 209 separate claims had been filed as a part of MDL No. 2545 – In Re: Testosterone Replacement Therapy Products Liability Litigation.

Recent developments in the lawsuits for Testim and other testosterone products include an August 22Case Management Conference in which the legal counsel for the plaintiffs and the defendants met to discuss the procedure for discovery, according to court documents. Among the defendants is Auxilium Pharmaceuticals, the maker of Testim testosterone therapy.

Testim and other testosterone therapies have FDA approval only for patients who are documented to have a low level of natural testosterone and also suffer from associated health problems, according to the January 31, 2014 Drug Safety Communication. Other complaints can be misdiagnosed as hypogonadism; the only way to confirm hypoginadism is through a blood test. The Journal of the American Medical Institute published research showing that as many as 25% of men taking testosterone drugs such as Testim never had their testosterone levels tested.****

Nationally respected for its work in product safety litigation against national and multi-national entities, The Onder Law Firm has committed its significant resources to providing legal representation for Testim lawsuits. Persons who suffered from a heart attack or stroke while using Testim testosterone may have grounds to file a Testim lawsuit. Individuals who meet this description are entitled to a no-cost, no-obligation consultation through the firm's Testim Testerone Lawsuit Center website.

The Onder Law Firm welcomes Testim lawsuit or other testosterone case inquiries from law firms in regards to handling them or working as co-counsel.

About The Onder Law Firm
Onder, Shelton, O'Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from attorneys handling Testim lawsuits at TestimTestosteroneLawsuitCenter.com.

*jama.jamanetwork.com/article.aspx?articleid=1764051
**fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm384225.htm
***fda.gov/AdvisoryCommittees/Calendar/ucm404905.htm
****archinte.jamanetwork.com/article.aspx?articleid=1691925

Read the full story at http://www.prweb.com/releases/testim-lawsuits/testim-lawsuit-news/prweb12129029.htm

Copyright:  (c) 2014 PRWEB.COM Newswire
Wordcount:  688

Advisor News

  • Iowa House backs temporary tax hike to fill Medicaid gap
  • Advisors in Texas and California banned for fraud scams
  • House panel votes to raise certain taxes, transfer money to offset Medicaid shortfall
  • Iowa House backs temporary tax hike to fill Medicaid gap
  • Charitable giving planning can strengthen advisor/client relationships
More Advisor News

Annuity News

  • LIMRA: Final retail annuity sales total $464.1 billion in 2025
  • How annuities can enhance retirement income for post-pension clients
  • We can help find a loved one’s life insurance policy
  • 2025: A record-breaking year for annuity sales via banks and BDs
  • Lincoln Financial launches two new FIAs
More Annuity News

Health/Employee Benefits News

  • Mark Farrah Associates’ Health Coverage Portal Simplifies Health Insurance Data Analytics
  • American healthcare: High $26,000 premiums and diminishing returns
  • Marion County Democrats turn out for 'Pancakes and Politics'
  • Commentary: Health care is the way for Democrats to win
  • Lincoln Financial Recognized for Leadership in the Advancement of Long-Term Care Planning
More Health/Employee Benefits News

Life Insurance News

  • Retirement Tax Worries on the Rise Among Americans, Allianz Life Study Finds
  • Lincoln Financial Recognized for Leadership in the Advancement of Long-Term Care Planning
  • Best’s Market Segment Report: AM Best Maintains Stable Outlook on UK Non-Life Insurance Segment Despite Elevated Geopolitical Risks
  • Murray Giles Hulse
  • New individual life premium hits record-setting $17.5B in 2025
More Life Insurance News

- Presented By -

Top Read Stories

More Top Read Stories >

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Elevate Your Practice with Pacific Life
Taking your business to the next level is easier when you have experienced support.

Your Cap. Your Term. Locked.
Oceanview CapLock™. One locked cap. No annual re-declarations. Clear expectations from day one.

Ready to make your client presentations more engaging?
EnsightTM marketing stories, available with select Allianz Life Insurance Company of North America FIAs.

Unlock the Future of Index-Linked Solutions
Join industry leaders shaping next-gen index strategies, distribution, and innovation.

Press Releases

  • LifeSecure Insurance Company Announces Retirement of Brian Vestergaard, Additions to Executive Leadership
  • RFP #T02226
  • YourMedPlan Appoints Kevin Mercier as Executive Vice President of Business Development
  • ICMG Golf Event Raises $43,000 for Charity During Annual Industry Gathering
  • RFP #T25521
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.
Insurance News | InsuranceNewsNet